LUSSANA, FEDERICO

LUSSANA, FEDERICO  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 65 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda 2024 Lussana, FedericoTurrini, Mauro + Article (author) -
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study 2023 Lussana, Federico + Article (author) -
Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 2023 Lussana, Federico + Article (author) -
Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective? 2023 Bosi, AlessandroMazzon, FedericoLussana, FedericoFattizzo, Bruno + Article (author) -
Optimal Use of Novel Immunotherapeutics in B-Cell Precursor ALL 2023 Lussana, FedericoCavallaro, GianlucaDe Simone, PantaleoRambaldi, Alessandro Article (author) -
Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1-JAK2 positive myeloid sarcoma and acute B-lymphoblastic leukemia 2022 Rizzuto, GiulianaLussana, FedericoRambaldi, Alessandro + Article (author) -
{COVID}-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus {ALL} report 2022 Federico LussanaCarla Mazzone + Article (author) -
Real-World Multicenter Experience in Tumor Debulking Prior to Blinatumomab Administration in Adult Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia 2021 Lussana, Federico + Article (author) -
Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell–Redirected Bispecific Antibodies 2021 Federico LussanaAlessandro Rambaldi + Article (author) -
Skip pattern approach toward the early access of innovative anticancer drugs 2021 de Braud F.Lussana F.Rambaldi A.Verderio P. + Article (author) -
Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies 2021 Chiara CaprioliAlessandra WeberAlessandro RambaldiFederico Lussana + Article (author) -
Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell-Redirected Bispecific Antibodies 2021 Lussana, FedericoGritti, GiuseppeRambaldi, Alessandro Article (author) -
Mrd‐based therapeutic decisions in genetically defined subsets of adolescents and young adult philadelphia‐negative all 2021 Lussana F.Rambaldi A. + Article (author) -
Concurrent diagnosis of acute myeloid leukemia and symptomatic covid-19 infection: A case report successfully treated with azacitidine-venetoclax combination 2021 Cavallaro G.Rambaldi A.Lussana F. + Article (author) -
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 2020 Lussana, FedericoRambaldi, Alessandro + Article (author) -
Evaluation of platelet function in essential thrombocythemia under different analytical conditions 2020 Lussana, FedericoFemia, Eti AlessandraPugliano, MariateresaPodda, GianmarcoRazzari, CristinaCaberlon, SabrinaGerli, GiancarlaCattaneo, Marco + Article (author) -
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG) 2020 Roberta CAVAGNAFederico LussanaChiara CaprioliPaolo CorradiniNicola FracchiollaAlessandro Rambaldi + Article (author) -
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study 2020 Cattaneo M.Lussana F. + Article (author) -
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06 2020 Caprioli, ChiaraLussana, FedericoCavagna, RobertaOldani, ElenaBorlenghi, ErikaCorradini, PaoloCortelezzi, AgostinoRambaldi, Alessandro + Article (author) -
National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia? 2020 Lussana F + Article (author) -